Stanford University
Stanford, California, 94305, United States
NCT Number: NCT05588895
This is a prospective randomized controlled trial assessing the impact of notifying patients and their clinicians of an incidental finding of coronary artery calcification (CAC) indicating increased cardiovascular risk. Patients will be identified through completed radiology orders for non-gated, non-contrast chest CT in the appropriate clinical context and then will have an EHR screen for inclusion criteria. The presence of CAC will be confirmed by a radiologist. Eligible patients will be randomized to CAC notification or usual care using a 1:1 stratified block randomization method based on baseline ASCVD.
Looking for future studies?
Notify Me18 year–84 year
All sexes
Interventional
Not applicable
Stanford, California, 94305, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
For patients randomized to notification, the affiliated non-EP cardiologist, if present, or if patient does not have one, the PCP will be notified and will receive an electronic health record (EHR) message notifying them of the presence of CAC (with images) and the ACC/AHA guideline recommendation to consider starting statin therapy. Simultaneously, the patient will be notified via a MyHealth message describing the presence of CAC with personalized scan images, its significance, and the recommendation that statin therapy should be considered.
For the notification arm, we will check for either statin prescription or a documented discussion in the EHR at 2 months. For those not prescribed a statin and without a documented discussion in Epic at 2 months follow-up, we will send a repeat notification to their home address and to their affiliated clinician.
Time frame: Baseline through Month 6
6-month new statin prescription rate
Time frame: Month 6
6-month assessment of statin prescription rates
Time frame: Baseline and Month 6
Time frame: Baseline and Month 6
This outcome measures the 10 year risk of ASCVD events.
Time frame: Baseline through Month 6
This outcome assesses healthcare resource use (primary care clinical encounters, cardiology referrals, cardiac testing).
Stanford University
Other
NOTIFY 2: Picture of Incidental Calcium To Understand Risk Estimate
Acronym: PICTURE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05858879
ASCVD, Coronary Artery Calcification
Stanford, California, United States
View Trial DetailsNCT04253171
Arterial Occlusive Diseases, Arteriosclerosis
Leuven, Belgium
View Trial DetailsNCT05283538
Autoimmune Diseases, Coronary Artery Calcification
Poitiers, France
View Trial DetailsNCT06379295
Arterial Occlusive Diseases, Arteriosclerosis
Orléans, France
View Trial Details